- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.70 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 4 x MCV: 5-[2-(2,5-dimethoxyphenyl)ethyl]thieno[2,3-d]pyrimidine-2,4-diamine(Non-covalent)
MCV.2: 14 residues within 4Å:- Chain A: R.34, S.115, F.117, D.181, C.188, F.191, Y.194, G.225, L.228, L.229, P.230, M.233, W.241
- Ligands: NAP.1
11 PLIP interactions:11 interactions with chain A- Hydrophobic interactions: A:F.117, A:L.229, A:P.230, A:W.241
- Hydrogen bonds: A:R.34, A:S.115, A:S.115, A:Y.194
- Water bridges: A:R.34
- pi-Stacking: A:F.117, A:F.117
MCV.5: 14 residues within 4Å:- Chain B: R.34, S.115, F.117, D.181, C.188, Y.194, G.225, V.226, L.228, L.229, P.230, M.233, W.241
- Ligands: NAP.4
9 PLIP interactions:9 interactions with chain B- Hydrophobic interactions: B:F.117, B:L.229, B:W.241
- Hydrogen bonds: B:R.34, B:S.115, B:Y.194
- Water bridges: B:R.34
- pi-Stacking: B:F.117, B:F.117
MCV.9: 15 residues within 4Å:- Chain C: R.34, S.115, F.117, D.181, C.188, F.191, Y.194, G.225, V.226, L.229, P.230, M.233, E.237, W.241
- Ligands: NAP.8
9 PLIP interactions:9 interactions with chain C- Hydrophobic interactions: C:F.117, C:L.229, C:W.241
- Hydrogen bonds: C:R.34, C:S.115, C:S.115, C:L.228
- pi-Stacking: C:F.117, C:F.117
MCV.11: 15 residues within 4Å:- Chain D: R.34, S.115, F.117, D.181, C.188, Y.194, G.225, V.226, L.228, L.229, P.230, M.233, W.241
- Ligands: NAP.10, ACT.12
9 PLIP interactions:9 interactions with chain D- Hydrophobic interactions: D:F.117, D:L.229, D:W.241
- Hydrogen bonds: D:R.34, D:S.115, D:S.115, D:L.228
- pi-Stacking: D:F.117, D:F.117
- 4 x ACT: ACETATE ION(Non-functional Binders)
ACT.3: 3 residues within 4Å:- Chain A: R.242, R.250, E.251
3 PLIP interactions:3 interactions with chain A- Water bridges: A:E.235
- Salt bridges: A:R.242, A:R.250
ACT.6: 4 residues within 4Å:- Chain B: A.232, M.233, G.234, E.235
6 PLIP interactions:6 interactions with chain B- Hydrogen bonds: B:E.235
- Water bridges: B:M.233, B:K.238, B:K.238, B:K.238
- Salt bridges: B:K.238
ACT.7: 2 residues within 4Å:- Chain B: Y.54, V.78
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:Y.54, B:Y.54
ACT.12: 6 residues within 4Å:- Chain A: H.287
- Chain D: C.188, M.189, K.240, W.241
- Ligands: MCV.11
3 PLIP interactions:2 interactions with chain D, 1 interactions with chain A- Hydrophobic interactions: D:W.241
- Hydrogen bonds: D:M.189
- Salt bridges: A:H.287
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Dawson, A. et al., High-resolution structures of Trypanosoma brucei pteridine reductase ligand complexes inform on the placement of new molecular entities in the active site of a potential drug target. Acta Crystallogr.,Sect.D (2010)
- Release Date
- 2010-06-02
- Peptides
- Pteridine reductase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
SMTL ID : 3mcv.1
Structure of PTR1 from Trypanosoma brucei in ternary complex with 2,4-diamino-5-[2-(2,5-dimethoxyphenyl)ethyl]thieno[2,3-d]-pyrimidine and NADP+
Pteridine reductase
Related Entries With Identical Sequence
2x9g.1 | 2x9n.1 | 2x9v.1 | 2yhi.1 | 2yhu.1 | 3bmc.1 | 3bmn.1 | 3bmo.1 | 3bmq.1 | 3gn1.1 | 3gn2.1 | 3jq6.1 | 3jq7.1 | 3jq8.1 | 3jq9.1 | 3jqa.1 | 3jqb.1 | 3jqc.1 | 3jqd.1 | 3jqe.1 | 3jqf.1 | 3jqg.1 | 4cl8.1 | 4cld.1 | 4cle.1 | 4clh.1 | 4clo.1 | 4clr.1 | 4clx.1 | 4cm1.1 more...less...4cm3.1 | 4cm4.1 | 4cm5.1 | 4cm6.1 | 4cm7.1 | 4cm8.1 | 4cm9.1 | 4cma.1 | 4cmb.1 | 4cmc.1 | 4cme.1 | 4cmg.1 | 4cmi.1 | 4cmj.1 | 4cmk.1 | 5jcj.1 | 5jcx.1 | 5jdc.1 | 5jdi.1 | 5k6a.1 | 6gcl.1 | 6gcp.1 | 6gcq.1 | 6gd0.1 | 6gd4.1 | 6gdo.1 | 6gdp.1 | 6gex.1 | 6gey.1 | 6hnc.1 | 6hnr.1 | 6how.1 | 6rx0.1 | 6rx5.1 | 6rx6.1 | 6tbx.1 | 7opj.1 | 8of2.1